Citadel Advisors’s Enlivex Ltd ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-713
Closed -$7.52K 13279
2025
Q4
$7.52K Buy
+713
New +$10.6K ﹤0.01% 12449
2025
Q2
Sell
-473
Closed -$6.89K 13173
2025
Q1
$6.89K Sell
473
-134
-22% -$2.23K ﹤0.01% 13722
2024
Q4
$10.6K Buy
607
+407
+204% +$7.92K ﹤0.01% 13594
2024
Q3
$5.04K Sell
200
-27
-12% -$550 ﹤0.01% 13523
2024
Q2
$4.83K Sell
227
-920
-80% -$24.4K ﹤0.01% 13454
2024
Q1
$65.2K Buy
+1,147
New +$56K ﹤0.01% 11904
2023
Q4
Sell
-327
Closed -$7.74K 14501
2023
Q3
$7.74K Sell
327
-360
-52% -$12.5K ﹤0.01% 13243
2023
Q2
$27.1K Buy
687
+247
+56% +$10.3K ﹤0.01% 12457
2023
Q1
$24K Sell
440
-1,753
-80% -$106K ﹤0.01% 12919
2022
Q4
$128K Sell
2,193
-1,227
-36% -$79.2K ﹤0.01% 10847
2022
Q3
$218K Buy
+3,420
New +$250K ﹤0.01% 10236
2021
Q3
Sell
-2,260
Closed -$302K 13973
2021
Q2
$302K Sell
2,260
-60
-3% -$9.03K ﹤0.01% 11255
2021
Q1
$386K Sell
2,320
-1,927
-45% -$397K ﹤0.01% 10268
2020
Q4
$537K Buy
+4,247
New +$683K ﹤0.01% 8007

Other funds holding ENLV

Citadel Advisors's ENLV Position: Q1 2026 in Review

Citadel Advisors increased its Enlivex Ltd (ENLV) stake by 9.3% in Q1 2026, buying an estimated $2.5K and bringing the position to 1,864 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #12616.

Citadel Advisors first reported a position in ENLV in Q3 2016 and has held it in 14 quarters since. The position peaked at $232K in Q4 2022. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

  • Citadel Advisors held 1,864 shares of Enlivex Ltd worth $26K as of Q1 2026.
  • Citadel Advisors bought 158 Enlivex Ltd shares in Q1 2026, an estimated $2.5K.
  • Enlivex Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12616 holding.
  • Citadel Advisors first reported a position in Enlivex Ltd in Q3 2016 and has held it in 14 quarters since.
  • Citadel Advisors's Enlivex Ltd position peaked at $232K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.